Latest Insider Transactions at Equity Lifestyle Properties Inc (ELS)
This section provides a real-time view of insider transactions for Equity Lifestyle Properties Inc (ELS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EQUITY LIFESTYLE PROPERTIES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EQUITY LIFESTYLE PROPERTIES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2024
|
Constance Freedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
372
+4.36%
|
$19,716
$53.74 P/Share
|
|
Jun 04
2024
|
Scott R Peppet Director |
SELL
Bona fide gift
|
Direct |
2,500
-16.02%
|
-
|
|
May 01
2024
|
Scott R Peppet Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,736
+7.84%
|
$164,160
$60.29 P/Share
|
|
May 01
2024
|
Radhika Papandreou Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,529
+27.34%
|
$151,740
$60.29 P/Share
|
|
May 01
2024
|
Patrick Waite President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.0%
|
$306
$51.25 P/Share
|
|
May 01
2024
|
Constance Freedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.33%
|
$1,326
$51.25 P/Share
|
|
May 01
2024
|
Derrick Burks Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,612
+14.02%
|
$156,720
$60.29 P/Share
|
|
May 01
2024
|
Philip Calian Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,276
+0.38%
|
$196,560
$60.29 P/Share
|
|
May 01
2024
|
David J Contis Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,944
+19.01%
|
$176,640
$60.29 P/Share
|
|
May 01
2024
|
Andrew Berkenfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,529
+15.56%
|
$151,740
$60.29 P/Share
|
|
Apr 26
2024
|
David J Contis Director |
BUY
Bona fide gift
|
Indirect |
599
+0.87%
|
-
|
|
Apr 26
2024
|
David J Contis Director |
SELL
Bona fide gift
|
Direct |
599
-16.85%
|
-
|
|
Apr 26
2024
|
Thomas Heneghan Chairman of the Board |
BUY
Bona fide gift
|
Indirect |
780
+0.09%
|
-
|
|
Apr 26
2024
|
Thomas Heneghan Chairman of the Board |
SELL
Bona fide gift
|
Direct |
780
-0.25%
|
-
|
|
Apr 25
2024
|
David J Contis Director |
BUY
Bona fide gift
|
Indirect |
772
+1.15%
|
-
|
|
Apr 25
2024
|
David J Contis Director |
SELL
Bona fide gift
|
Direct |
772
-13.56%
|
-
|
|
Apr 25
2024
|
Thomas Heneghan Chairman of the Board |
BUY
Bona fide gift
|
Indirect |
686
+0.11%
|
-
|
|
Apr 25
2024
|
Thomas Heneghan Chairman of the Board |
SELL
Bona fide gift
|
Direct |
686
-0.33%
|
-
|
|
Apr 01
2024
|
Constance Freedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
297
+3.69%
|
$16,038
$54.74 P/Share
|
|
Apr 01
2024
|
Sheli Z Rosenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
229
+0.03%
|
$12,366
$54.74 P/Share
|
|
Feb 06
2024
|
Patrick Waite President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
21,433
+8.12%
|
$1,436,011
$67.05 P/Share
|
|
Feb 06
2024
|
Larisa Drake EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,473
+11.17%
|
$366,691
$67.05 P/Share
|
|
Feb 06
2024
|
David P Eldersveld EVP, CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
14,914
+14.05%
|
$999,238
$67.05 P/Share
|
|
Feb 06
2024
|
Marguerite M Nader President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
27,125
+8.45%
|
$1,817,375
$67.05 P/Share
|
|
Feb 06
2024
|
Paul Seavey EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,433
+12.62%
|
$1,436,011
$67.05 P/Share
|
|
Feb 01
2024
|
Constance Freedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.27%
|
$1,140
$57.54 P/Share
|
|
Feb 01
2024
|
Patrick Waite President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.0%
|
$285
$57.54 P/Share
|
|
Jan 30
2024
|
Patrick Waite President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,812
-0.54%
|
$317,592
$66.88 P/Share
|
|
Jan 30
2024
|
Larisa Drake EVP & Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
883
-0.57%
|
$58,278
$66.88 P/Share
|
|
Jan 30
2024
|
David P Eldersveld EVP, CLO and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,663
-0.85%
|
$175,758
$66.88 P/Share
|
|
Jan 30
2024
|
Marguerite M Nader President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,684
-0.62%
|
$441,144
$66.88 P/Share
|
|
Jan 30
2024
|
Paul Seavey EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,812
-0.93%
|
$317,592
$66.88 P/Share
|
|
Jan 26
2024
|
Patrick Waite President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,103
-0.46%
|
$138,798
$66.35 P/Share
|
|
Jan 26
2024
|
Larisa Drake EVP & Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
528
-0.67%
|
$34,848
$66.35 P/Share
|
|
Jan 26
2024
|
David P Eldersveld EVP, CLO and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,398
-0.87%
|
$92,268
$66.35 P/Share
|
|
Jan 26
2024
|
Marguerite M Nader President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,616
-0.47%
|
$172,656
$66.35 P/Share
|
|
Jan 26
2024
|
Paul Seavey EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,102
-0.79%
|
$138,732
$66.35 P/Share
|
|
Jan 02
2024
|
Sheli Z Rosenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
208
+0.03%
|
$12,272
$59.96 P/Share
|
|
Jan 02
2024
|
Constance Freedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
271
+3.51%
|
$15,989
$59.96 P/Share
|
|
Nov 01
2023
|
Patrick Waite President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.0%
|
$265
$53.01 P/Share
|
|
Nov 01
2023
|
Constance Freedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.25%
|
$954
$53.01 P/Share
|
|
Oct 25
2023
|
David J Contis Director |
BUY
Bona fide gift
|
Indirect |
490
+2.23%
|
-
|
|
Oct 25
2023
|
David J Contis Director |
SELL
Bona fide gift
|
Direct |
490
-18.62%
|
-
|
|
Oct 25
2023
|
Thomas Heneghan Chairman of the Board |
BUY
Bona fide gift
|
Indirect |
490
+0.16%
|
-
|
|
Oct 25
2023
|
Thomas Heneghan Chairman of the Board |
SELL
Bona fide gift
|
Direct |
490
-0.47%
|
-
|
|
Oct 02
2023
|
Paul Seavey EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.0%
|
$54
$54.15 P/Share
|
|
Oct 02
2023
|
Constance Freedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
300
+4.03%
|
$16,200
$54.15 P/Share
|
|
Oct 02
2023
|
Sheli Z Rosenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
231
+0.03%
|
$12,474
$54.15 P/Share
|
|
Aug 01
2023
|
Constance Freedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.22%
|
$855
$57.09 P/Share
|
|
Aug 01
2023
|
Patrick Waite President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.0%
|
$285
$57.09 P/Share
|